REGENXBIO Inc. (RGNX) Gross margin 2016–2024
REGENXBIO Inc. (RGNX) gross margin by fiscal year — reported gross profit divided by reported revenue.
59.7%FY2024 · since FY2016: 97.9% → 59.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 59.7% | +1.0 pp |
| FY2023 | 58.8% | +7.2 pp |
| FY2022 | 51.6% | -37.4 pp |
| FY2021 | 89.0% | +12.1 pp |
| FY2020 | 76.9% | +0.3 pp |
| FY2019 | 76.6% | -19.0 pp |
| FY2018 | 95.6% | +12.0 pp |
| FY2017 | 83.6% | -14.3 pp |
| FY2016 | 97.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice